ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Awarded A$8.8M Aust Govt Grant for Sarcoma Trial
|
|
Linkman19
|
9 |
3.3K |
10 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
9
|
3.3K
|
10
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Signs Agreement Across Globally Significant Portfolio
|
|
Linkman19
|
27 |
9.0K |
2 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
27
|
9.0K
|
2
|
|
ASX - By Stock
|
APG |
Re:
Ann: Annual Report to shareholders
|
|
Linkman19
|
16 |
5.4K |
2 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
16
|
5.4K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
History can repeat itself
|
|
Linkman19
|
55 |
21K |
1 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
55
|
21K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: DARRT-2 Trial Commences in the U.S.
|
|
Linkman19
|
14 |
3.6K |
3 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
14
|
3.6K
|
3
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Q1 FY22 Activity Report and Appendix 4C
|
|
Linkman19
|
13 |
4.7K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
13
|
4.7K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Patent Granted for Veyonda and Low Dose Chemotherapy
|
|
Linkman19
|
36 |
10K |
1 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
36
|
10K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Patent Granted for Veyonda and Low Dose Chemotherapy
|
|
Linkman19
|
36 |
10K |
8 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
36
|
10K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Jobkeeper s323DB Notice
|
|
Linkman19
|
22 |
4.4K |
2 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
22
|
4.4K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Linkman19
|
11 |
5.3K |
7 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
11
|
5.3K
|
7
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR FY21 Annual Report
|
|
Linkman19
|
54 |
21K |
2 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
54
|
21K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Trinity Health Purchases Mach7 PACS Solution
|
|
Linkman19
|
29 |
12K |
6 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
29
|
12K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Achieves Important U.S. Patent Claims
|
|
Linkman19
|
16 |
5.1K |
5 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
16
|
5.1K
|
5
|
|
ASX - By Stock
|
KSS |
Re:
$1 party and new highs welcomed by shareholders
|
|
Linkman19
|
161 |
43K |
3 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
161
|
43K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Change in substantial holding from AEF
|
|
Linkman19
|
3 |
1.9K |
2 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR FY21 Results Presentation
|
|
Linkman19
|
7 |
2.7K |
0 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
7
|
2.7K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Preliminary Final Report and Audited Full Year Accounts
|
|
Linkman19
|
9 |
4.0K |
2 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
9
|
4.0K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
|
|
Linkman19
|
49 |
14K |
15 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
49
|
14K
|
15
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Announces FY21 Results
|
|
Linkman19
|
36 |
17K |
4 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
36
|
17K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
Linkman19
|
71 |
22K |
5 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
71
|
22K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
Linkman19
|
71 |
22K |
3 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
71
|
22K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Licenses eUnity Viewer to St. Lukes Boise
|
|
Linkman19
|
19 |
7.0K |
6 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
19
|
7.0K
|
6
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Q4 FY21 Activity Report and Appendix 4C
|
|
Linkman19
|
29 |
11K |
5 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
29
|
11K
|
5
|
|
ASX - By Stock
|
M7T |
Re:
Is $1.50 the new base ?
|
|
Linkman19
|
103 |
47K |
2 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
103
|
47K
|
2
|
|
ASX - By Stock
|
AVA |
Re:
Ann: AVA FY2021 Trading Update & Outlook
|
|
Linkman19
|
129 |
46K |
1 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
129
|
46K
|
1
|
|
ASX - By Stock
|
AVA |
Re:
Ann: AVA FY2021 Trading Update & Outlook
|
|
Linkman19
|
129 |
46K |
2 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
129
|
46K
|
2
|
|
ASX - By Stock
|
LCL |
Re:
Ann: Massive gold intercepts continue to expand Tesorito high gra
|
|
Linkman19
|
75 |
22K |
21 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
75
|
22K
|
21
|
|
ASX - By Stock
|
APG |
Re:
Ann: Revised Securities Trading Policy
|
|
Linkman19
|
57 |
15K |
1 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
57
|
15K
|
1
|
|
ASX - By Stock
|
APG |
Re:
Ann: Suspension from Official Quotation
|
|
Linkman19
|
109 |
27K |
0 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
109
|
27K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Secures Key European Patent Allowance for Veyonda
|
|
Linkman19
|
40 |
14K |
5 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
40
|
14K
|
5
|
|
ASX - By Stock
|
APG |
Re:
Ann: Suspension from Official Quotation
|
|
Linkman19
|
109 |
27K |
7 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
109
|
27K
|
7
|
|
ASX - By Stock
|
BUD |
Re:
Ann: Director Resignations, Appointments and Company Update
|
|
Linkman19
|
57 |
35K |
0 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
57
|
35K
|
0
|
|
ASX - By Stock
|
APG |
Re:
Ann: Pause in Trading
|
|
Linkman19
|
11 |
2.8K |
3 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
11
|
2.8K
|
3
|
|
ASX - By Stock
|
APG |
Re:
Ann: Queries Received from ASX
|
|
Linkman19
|
20 |
6.0K |
0 |
14/06/21 |
14/06/21 |
ASX - By Stock
|
20
|
6.0K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Is $1.50 the new base ?
|
|
Linkman19
|
103 |
47K |
1 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
103
|
47K
|
1
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Investor Presentation June 2021
|
|
Linkman19
|
22 |
6.6K |
7 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
22
|
6.6K
|
7
|
|
ASX - By Stock
|
BUD |
Re:
Ann: Director Resignations, Appointments and Company Update
|
|
Linkman19
|
57 |
35K |
11 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
57
|
35K
|
11
|
|
ASX - By Stock
|
AVA |
Re:
Ann: Ceasing to be a substantial holder
|
|
Linkman19
|
28 |
9.6K |
1 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
28
|
9.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
anybody aware what this will indicate for the SP ?
|
|
Linkman19
|
2 |
1.6K |
3 |
05/06/21 |
05/06/21 |
ASX - By Stock
|
2
|
1.6K
|
3
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Q3 FY21 Results Presentation
|
|
Linkman19
|
102 |
40K |
11 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
102
|
40K
|
11
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Investor Presentation
|
|
Linkman19
|
15 |
8.5K |
1 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
15
|
8.5K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
Linkman19
|
24 |
8.4K |
5 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
24
|
8.4K
|
5
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR Q3 FY21 Results Presentation
|
|
Linkman19
|
102 |
40K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
102
|
40K
|
3
|
|
ASX - By Stock
|
KSS |
Re:
$1 party and new highs welcomed by shareholders
|
|
Linkman19
|
161 |
43K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
161
|
43K
|
3
|
|
ASX - By Stock
|
KSS |
Re:
$1 party and new highs welcomed by shareholders
|
|
Linkman19
|
161 |
43K |
1 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
161
|
43K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: New Independent Trial Data Supports Potential of Veyonda
|
|
Linkman19
|
41 |
13K |
6 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
41
|
13K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Proactive CEO Interview
|
|
Linkman19
|
10 |
4.4K |
16 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
10
|
4.4K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted Chinese patent for its LAG-3 candidate Efti
|
|
Linkman19
|
87 |
40K |
11 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
87
|
40K
|
11
|
|
ASX - By Stock
|
NOX |
Re:
Patent news
|
|
Linkman19
|
31 |
11K |
3 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
31
|
11K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Is $1.50 the new base ?
|
|
Linkman19
|
103 |
47K |
4 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
103
|
47K
|
4
|
|